The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Century Therapeutics Inc (NASDAQ: IPSC) closed the day trading at $0.57 down -4.74% from the previous closing price of $0.59. In other words, the price has decreased by -$4.74 from its previous closing price. On the day, 0.51 million shares were traded.
Ratios:
For a better understanding of IPSC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.70 and its Current Ratio is at 11.70. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 08, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On August 28, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $28 to $5.
On December 27, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $19.Chardan Capital Markets initiated its Buy rating on December 27, 2022, with a $19 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 09 ’25 when Carr Douglas sold 4,904 shares for $0.62 per share. The transaction valued at 3,050 led to the insider holds 405,982 shares of the business.
Farid Adrienne sold 552 shares of IPSC for $343 on Jun 09 ’25. The Chief Operations Officer now owns 250,141 shares after completing the transaction at $0.62 per share. On Jun 09 ’25, another insider, Pfeiffenberger Brent, who serves as the President and CEO of the company, sold 475 shares for $0.62 each. As a result, the insider received 295 and left with 1,681,783 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42 while its Price-to-Book (P/B) ratio in mrq is 0.20.
Stock Price History:
Over the past 52 weeks, IPSC has reached a high of $3.29, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is 2.26%, while the 200-Day Moving Average is calculated to be -40.64%.
Shares Statistics:
A total of 86.15M shares are outstanding, with a floating share count of 40.60M. Insiders hold about 52.88% of the company’s shares, while institutions hold 28.86% stake in the company.
